Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Interventions

pembrolizumab 161 Nivolumab 133 Ipilimumab 78 Cyclophosphamide 47 Specimen Handling 43 Magnetic Resonance Spectroscopy 39 cemiplimab 35 Biopsy 31 fludarabine 29 trametinib 24 relatlimab 24 binimetinib 23 Interleukin-2 22 fludarabine phosphate 21 dabrafenib 20 atezolizumab 19 Radiotherapy 19 Opdualag 19 aldesleukin 18 Radiosurgery 18 CTLA-4 Antigen 18 encorafenib 17 Blood Specimen Collection 17 avelumab 14 Immunoglobulin G 14 Disulfides 13 lifileucel 11 lenvatinib 11 Bevacizumab 11 Paclitaxel 10

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

secukinumab × Dermatologic × 1 year × Clear all

NCT07237594 2026-06-04

REPLAY

Duke University

Phase 1 Recruiting

Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡